{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:24:29Z","timestamp":1791267869925,"version":"4.1.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1097\/inf.0b013e3181e74a2f","type":"journal-article","created":{"date-parts":[[2010,6,10]],"date-time":"2010-06-10T06:50:36Z","timestamp":1276152636000},"page":"721-727","source":"Crossref","is-referenced-by-count":80,"title":["Birth Defects Among Children Born to Human Immunodeficiency Virus-Infected Women"],"prefix":"10.1097","volume":"29","author":[{"given":"Susan B.","family":"Brogly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Abzug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Heather","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coleen K.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige L.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Oleske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Conway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhoda S.","family":"Sperling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Spiegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell B.","family":"Van Dyke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-10-20210202","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1517\/14740338.5.3.373","article-title":"Mitochondrial disease in the offspring as a result of antiretroviral therapy.","volume":"5","author":"Venhoff","year":"2006","journal-title":"Expert Opin Drug Saf"},{"key":"R3-10-20210202","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00002030-200201250-00025","article-title":"Myelomeningocele in a child with intrauterine exposure to efavirenz.","volume":"16","author":"Fundaro","year":"2002","journal-title":"AIDS"},{"key":"R4-10-20210202","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/archinte.162.3.355","article-title":"Periconceptional exposure to efavirenz and neural tube defects.","volume":"162","author":"De Santis","year":"2002","journal-title":"Arch Intern Med"},{"key":"R5-10-20210202","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/sj.jp.7211343","article-title":"Myelomeningocele in an infant with intrauterine exposure to efavirenz.","volume":"25","author":"Saitoh","year":"2005","journal-title":"J Perinatol"},{"key":"R6-10-20210202","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1001\/jama.280.17.1472-JFD80010-3-1","article-title":"From the food and drug administration.","volume":"280","author":"Nightingale","year":"1998","journal-title":"JAMA"},{"key":"R7-10-20210202","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/00126334-200304010-00006","article-title":"Exposure to antiretroviral therapy in utero or early life: the health of uninfected children born to HIV-infected women.","volume":"32","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R8-10-20210202","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/01.qai.0000156854.99769.a5","article-title":"Does highly active antiretroviral therapy increase the risk of congenital anomalies in HIV-infected women?","volume":"40","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R9-10-20210202","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/QAD.0b013e328326ca8e","article-title":"Antiretroviral therapy and congenital abnormalities in infants born to HIV-infected women in the UK and Ireland, 1990\u20132007.","volume":"23","author":"Townsend","year":"2009","journal-title":"AIDS"},{"key":"R10-10-20210202","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/sti.77.6.441","article-title":"Is first trimester exposure to the combination of antiretroviral therapy and folate antagonists a risk factor for congenital abnormalities?","volume":"77","author":"Jungmann","year":"2001","journal-title":"Sex Transm Infect"},{"key":"R11-10-20210202","first-page":"1","article-title":"Update on overall prevalence of major birth defects\u2014Atlanta, Georgia, 1978\u20132005.","volume":"57","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R12-10-20210202","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/QAI.0b013e31802e2229","article-title":"Assessment of birth defects according to maternal therapy among infants in the Women and Infants Transmission Study.","volume":"44","author":"Watts","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R14-10-20210202","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/QAD.0b013e3280d5a786","article-title":"In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children.","volume":"21","author":"Brogly","year":"2007","journal-title":"AIDS"},{"key":"R15-10-20210202","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1056\/NEJMoa067407","article-title":"First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects.","volume":"356","author":"Louik","year":"2007","journal-title":"N Engl J Med"},{"key":"R16-10-20210202","first-page":"65","article-title":"Reporting birth defects surveillance data 1968\u20132003.","volume":"79","author":"Correa","year":"2007","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"R17-10-20210202","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1097\/00002030-199814000-00012","article-title":"Safety of the maternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 Study.","volume":"12","author":"Sperling","year":"1998","journal-title":"AIDS"},{"key":"R18-10-20210202","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0735-1097(98)00449-5","article-title":"Prevalence of congenital cardiovascular malformations in children of human immunodeficiency virus-infected women: the prospective P2C2 HIV Multicenter Study.","volume":"32","author":"Lai","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"R19-10-20210202","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/S0735-1097(02)01886-7","article-title":"The incidence of congenital heart disease.","volume":"39","author":"Hoffman","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R20-10-20210202","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/aid.2006.0045","article-title":"Participation of HIV-infected pregnant women in research in the United States.","volume":"23","author":"Brogly","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R21-10-20210202","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/jama.288.2.189","article-title":"Two-dose intrapartum\/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.","volume":"288","author":"Dorenbaum","year":"2002","journal-title":"JAMA"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006454-201008000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:23:17Z","timestamp":1786040597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-201008000-00010"}},"subtitle":["Pediatric AIDS Clinical Trials Protocols 219 and 219C"],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e3181e74a2f","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}